Literature DB >> 12962137

Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK).

Ana M Cortizo1, María G Lettieri, Daniel A Barrio, Natalia Mercer, Susana B Etcheverry, Antonio D McCarthy.   

Abstract

An increase in the interaction between advanced glycation end-products (AGEs) and their receptor RAGE is believed to contribute to the pathogenesis of chronic complications of Diabetes mellitus, which can include bone alterations such as osteopenia. We have recently found that extracellular AGEs can directly regulate the growth and development of rat osteosarcoma UMR106 cells, and of mouse calvaria-derived MC3T3E1 osteoblasts throughout their successive developmental stages (proliferation, differentiation and mineralisation), possibly by the recognition of AGEs moieties by specific osteoblastic receptors which are present in both cell lines. In the present study we examined the possible expression of RAGE by UMR106 and MC3T3E1 osteoblastic cells, by immunoblot analysis. We also investigated whether short-, medium- or long-term exposure of osteoblasts to extracellular AGEs, could modify their affinity constant and maximal binding for AGEs (by 125I-AGE-BSA binding experiments), their expression of RAGE (by immunoblot analysis) and the activation status of the osteoblastic ERK 1/2 signal transduction mechanism (by immunoblot analysis for ERK and P-ERK). Our results show that both osteoblastic cell lines express readily detectable levels of RAGE. Short-term exposure of phenotypically mature osteoblastic UMR106 cells to AGEs decrease the cellular density of AGE-binding sites while increasing the affinity of these sites for AGEs. This culture condition also dose-dependently increased the expression of RAGE and the activation of ERK. In proliferating MC3T3E1 pre-osteoblasts, 24-72 h exposure to AGEs did not modify expression of RAGE, ERK activation or the cellular density of AGE-binding sites. However, it did change the affinity of these binding sites forAGEs, with both higher- and lower-affinity sites now being apparent. Medium-term ( 1 week) incubation of differentiated MC3T3E1 osteoblasts with AGEs, induced a simultaneous increase in RAGE expression and in the relative amount of P-ERK. Mineralising MC3T3E1 cultures grown for 3 weeks in the presence of extracellular AGEs showed a decrease both in RAGE and P-ERK expression. These results indicate that, in phenotypically mature osteoblastic cells, changes in ERK activation closely follow the AGEs-induced regulation of RAGE expression. Thus, the AGEs-induced biological effects that we have observed previously in osteoblasts, could be mediated by RAGE in the later stages of development, and mediated by other AGE receptors in the earlier pre-osteoblastic stage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962137     DOI: 10.1023/a:1024934008982

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  The effect of advanced glycation end-product formation upon cell-matrix interactions.

Authors:  R G Paul; A J Bailey
Journal:  Int J Biochem Cell Biol       Date:  1999-06       Impact factor: 5.085

2.  Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation.

Authors:  A D McCarthy; S B Etcheverry; A M Cortizo
Journal:  Acta Diabetol       Date:  1999-06       Impact factor: 4.280

3.  Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

Authors:  L F Lue; D G Walker; L Brachova; T G Beach; J Rogers; A M Schmidt; D M Stern; S D Yan
Journal:  Exp Neurol       Date:  2001-09       Impact factor: 5.330

4.  Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products.

Authors:  J Li; A M Schmidt
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

5.  Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells.

Authors:  A D McCarthy; S B Etcheverry; L Bruzzone; A M Cortizo
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.

Authors:  A Bierhaus; S Schiekofer; M Schwaninger; M Andrassy; P M Humpert; J Chen; M Hong; T Luther; T Henle; I Klöting; M Morcos; M Hofmann; H Tritschler; B Weigle; M Kasper; M Smith; G Perry; A M Schmidt; D M Stern; H U Häring; E Schleicher; P P Nawroth
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

8.  Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction.

Authors:  N Araki; T Higashi; T Mori; R Shibayama; Y Kawabe; T Kodama; K Takahashi; M Shichiri; S Horiuchi
Journal:  Eur J Biochem       Date:  1995-06-01

9.  Type I collagen influence on gene expression in UMR106-06 osteoblast-like cells is inhibited by genistein.

Authors:  S Celic; Y Katayama; P J Chilco; T J Martin; D M Findlay
Journal:  J Endocrinol       Date:  1998-09       Impact factor: 4.286

10.  Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia.

Authors:  Y Katayama; T Akatsu; M Yamamoto; N Kugai; N Nagata
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

View more
  24 in total

1.  Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats.

Authors:  Hongfeng Wang; Dorothee Weihrauch; Judy R Kersten; Jeffrey M Toth; Anthony G Passerini; Anita Rajamani; Sonja Schrepfer; John F LaDisa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

2.  Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells.

Authors:  Natalia Mercer; Hafiz Ahmed; Susana B Etcheverry; Gerardo R Vasta; Ana Maria Cortizo
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

3.  Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings.

Authors:  G Hein; C Weiss; G Lehmann; T Niwa; G Stein; S Franke
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

4.  CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway.

Authors:  Jen-Liang Su; Jean Chiou; Chih-Hsin Tang; Ming Zhao; Chun-Hao Tsai; Pai-Sheng Chen; Yi-Wen Chang; Ming-Hsien Chien; Chu-Ying Peng; Michael Hsiao; Ming-Liang Kuo; Men-Luh Yen
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

5.  Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice.

Authors:  Ngoc Nguyen; Veena Naik; Mei Y Speer
Journal:  Cardiovasc Pathol       Date:  2012-07-18       Impact factor: 2.185

6.  Advanced glycosylation end product promotes forkhead box O1 and inhibits Wnt pathway to suppress capacities of epidermal stem cells.

Authors:  Jie Zhu; Peng Wang; Zhimin Yu; Wei Lai; Yi Cao; Pinbo Huang; Qiaodong Xu; Menglei Yu; Junyao Xu; Zitong Huang; Bing Zeng
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 7.  Understanding RAGE, the receptor for advanced glycation end products.

Authors:  Angelika Bierhaus; Per M Humpert; Michael Morcos; Thoralf Wendt; Triantafyllos Chavakis; Bernd Arnold; David M Stern; Peter P Nawroth
Journal:  J Mol Med (Berl)       Date:  2005-08-24       Impact factor: 4.599

Review 8.  Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus.

Authors:  M Saito; K Marumo
Journal:  Osteoporos Int       Date:  2010-02       Impact factor: 4.507

Review 9.  The contribution of collagen crosslinks to bone strength.

Authors:  Patrick Garnero
Journal:  Bonekey Rep       Date:  2012-09-19

10.  Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products.

Authors:  A Schmidt; B Kuhla; K Bigl; G Münch; T Arendt
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.